{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:36:17Z","timestamp":1790062577122,"version":"4.0.1"},"update-to":[{"DOI":"10.1002\/14651858.cd011459","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000}}],"reference-count":92,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011459.pub2","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T14:58:49Z","timestamp":1588258729000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia"],"prefix":"10.1002","volume":"2020","author":[{"given":"Fionnuala","family":"Jordan","sequence":"additional","affiliation":[{"name":"School of Nursing and Midwifery; National University of Ireland Galway; Galway Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry J","family":"Quinn","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences; University of Glasgow; Glasgow UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"McGuinness","sequence":"additional","affiliation":[{"name":"Centre for Public Health; Queen's University Belfast; Belfast UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Passmore","sequence":"additional","affiliation":[{"name":"Centre for Public Health; Queen's University Belfast; Belfast UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P","family":"Kelly","sequence":"additional","affiliation":[{"name":"Pharmacology and Therapeutics; National University of Ireland Galway; Galway Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catrin","family":"Tudur Smith","sequence":"additional","affiliation":[{"name":"Department of Biostatistics; University of Liverpool; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Murphy","sequence":"additional","affiliation":[{"name":"School of Nursing and Midwifery; National University of Ireland Galway; Galway Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Declan","family":"Devane","sequence":"additional","affiliation":[{"name":"School of Nursing and Midwifery; National University of Ireland Galway; Galway Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,4,30]]},"reference":[{"issue":"7","key":"10.1002\/14651858.CD011459.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1371\/journal.pctr.0010033","article-title":"Cardiovascular and cerebrovascular events in the randomised, controlled Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT)","volume":"1","author":"ADAPT Research Group","year":"2006","journal-title":"PLoS Clinical Trials"},{"issue":"21","key":"10.1002\/14651858.CD011459.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1212\/01.wnl.0000260269.93245.d2","article-title":"Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial","volume":"68","author":"ADAPT Research Group","year":"2007","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD011459.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa1803955","article-title":"Effects of aspirin on disability-free survival in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD011459.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/JGP.0b013e31818cd3a4","article-title":"Cognitive and cerebral metabolic effects of celecoxib versus placebo in people with age-related memory loss: randomized controlled study","volume":"16","author":"Small","year":"2008","journal-title":"American Journal of Geriatric Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD011459.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/sj.npp.1300690","article-title":"A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment","volume":"30","author":"Thal","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD011459.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jalz.2014.03.009","article-title":"Follow-up evaluation of cognitive function in the randomized Alzheimer's disease anti-inflammatory prevention trial and its follow-up study","volume":"11","author":"ADAPT-FS Research Group","year":"2015","journal-title":"Alzheimer's & Dementia"},{"issue":"3","key":"10.1002\/14651858.CD011459.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1479-8301.2011.00379.x","article-title":"A comprehensive strategy for dementia from primary prevention to end-stage management","volume":"11","author":"Arai","year":"2011","journal-title":"Psychogeriatrics"},{"issue":"23","key":"10.1002\/14651858.CD011459.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1212\/01.wnl.0000313813.48505.86","article-title":"Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology","volume":"70","author":"Arvanitakis","year":"2008","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD011459.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0167-4943(96)00709-1","article-title":"Association of chronic non-steroidal anti-inflammatory drugs use and cognitive decline in non-demented elderly patients admitted to a Geriatric Evaluation and Rehabilitation Unit","volume":"23","author":"Bertozzi","year":"1996","journal-title":"Archives of Gerontology and Geriatrics"},{"issue":"22","key":"10.1002\/14651858.CD011459.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1212\/WNL.0b013e3181a18691","article-title":"Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort","volume":"72","author":"Breitner","year":"2009","journal-title":"Neurology"},{"issue":"11","key":"10.1002\/14651858.CD011459.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1001\/archneur.57.11.1586","article-title":"Anti-inflammatory drugs protect against Alzheimer disease at low doses","volume":"57","author":"Broe","year":"2000","journal-title":"Archives of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD011459.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2125.1994.tb04320.x","article-title":"Indomethacin and cognitive function in healthy elderly volunteers","volume":"38","author":"Bruce-Jones","year":"1994","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD011459.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1365-2796.2003.01154.x","article-title":"Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia","volume":"254","author":"Clarke","year":"2003","journal-title":"Journal of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011459.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/WAD.0b013e3181611024","article-title":"A randomized, double-blind, placebo controlled-trial of triflusal in mild cognitive impairment: the TRIMCI study","volume":"22","author":"G\u00f3mez-Isla","year":"2008","journal-title":"Alzheimer Disease and Associated Disorders"},{"issue":"3","key":"10.1002\/14651858.CD011459.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1212\/01.wnl.0000265223.25679.2a","article-title":"Does NSAID use modify cognitive trajectories in the elderly? The Cache County Study","volume":"69","author":"Hayden","year":"2007","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD011459.pub2-BIB0016|cit16","first-page":"497","article-title":"Efecto del ibuprofeno y \u00e1cido acetilsalic\u00edlico sobre el deterioro cognitivo, poder antioxidante total e isoprostanos en suero^ies","volume":"144","author":"Ib\u00e1\u00f1ez-Hern\u00e1ndez","year":"2008","journal-title":"Gaceta Medica de Mexico"},{"issue":"4","key":"10.1002\/14651858.CD011459.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0197-4580(02)00188-4","article-title":"Does aspirin or other NSAIDs reduce the risk of cognitive decline in elderly persons? Results from a population-based study","volume":"24","author":"Jonker","year":"2003","journal-title":"Neurobiology of Aging"},{"issue":"7601","key":"10.1002\/14651858.CD011459.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1136\/bmj.39166.597836.BE","article-title":"Low dose aspirin and cognitive function in the women's health study cognitive cohort","volume":"334","author":"Kang","year":"2007","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011459.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"eoo1288","DOI":"10.1136\/bmjopen-2012-001288","article-title":"Does low-dose acetylsalicylic acid prevent cognitive decline in women with high cardiovascular risk? A 5-year follow-up of a non-demented population-based cohort of Swedish elderly women","volume":"2","author":"Kern","year":"2012","journal-title":"BMJ Open"},{"issue":"3","key":"10.1002\/14651858.CD011459.pub2-BIB0020|cit20","first-page":"36","article-title":"Do NSAIDs prevent Alzheimer's disease?","volume":"36","author":"Kerst","year":"2002","journal-title":"Geneesmiddelenbulletin"},{"key":"10.1002\/14651858.CD011459.pub2-BIB0021|cit21","first-page":"S165","article-title":"Does low-dose acetyl-salicylic acid reduce cognitive decline in patient with mild cognitive impairment?","volume":"260","author":"Marini","year":"2013","journal-title":"Journal of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD011459.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000213340","article-title":"Lack of association of nonsteroidal anti-inflammatory drug use and cognitive decline in the elderly","volume":"38","author":"May","year":"1992","journal-title":"Gerontology"},{"key":"10.1002\/14651858.CD011459.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"a1198","DOI":"10.1136\/bmj.a1198","article-title":"Low dose aspirin and cognitive function in middle aged to elderly adults: randomised controlled trial","volume":"337","author":"Price","year":"2008","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD011459.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1161\/STROKEAHA.112.672451","article-title":"Effect of low-dose aspirin on functional outcome from cerebral vascular events in women","volume":"44","author":"Rist","year":"2013","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD011459.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/clpt.1993.115","article-title":"Adverse effects of low-dose aspirin in a healthy elderly population","volume":"54","author":"Silagy","year":"1993","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"13","key":"10.1002\/14651858.CD011459.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1212\/WNL.0b013e3181f52db1","article-title":"Nonsteroidal anti-inflammatory drugs are associated with increased neuritic plaques","volume":"75","author":"Sonnen","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD011459.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1212\/01.wnl.0000284596.95156.48","article-title":"NSAID use and dementia risk in the Cardiovascular Health Study: role of APOE and NSAID type","volume":"70","author":"Szekely","year":"2008","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD011459.pub2-BIB0028|cit28","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"issue":"9","key":"10.1002\/14651858.CD011459.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1474-4422(11)70072-2","article-title":"The projected effect of risk factor reduction on Alzheimer's disease prevalence","volume":"10","author":"Barnes","year":"2011","journal-title":"Lancet Neurology"},{"issue":"2","key":"10.1002\/14651858.CD011459.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1037\/1040-3590.8.2.145","article-title":"Revision of the Brief Visuospatial Memory tests: studies of normal performance, reliability, and validity","volume":"8","author":"Benedict","year":"1996","journal-title":"Psychological Assessment"},{"issue":"2","key":"10.1002\/14651858.CD011459.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/13854049108403297","article-title":"The Hopkins Verbal Learning Test: development of a new verbal memory test with six equivalent forms","volume":"5","author":"Brandt","year":"1991","journal-title":"Clinical Neuropsychologist"},{"issue":"11","key":"10.1002\/14651858.CD011459.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardiovascular events associated with rofecoxib in colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD011459.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2105\/AJPH.88.9.1337","article-title":"Projections of Alzheimer's disease in the united states and public health impact of delaying disease onset","volume":"88","author":"Brookmeyer","year":"1998","journal-title":"American Journal of Public Health"},{"issue":"3","key":"10.1002\/14651858.CD011459.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ncl.2007.04.003","article-title":"Subcortical ischaemic vascular dementia","volume":"25","author":"Chui","year":"2007","journal-title":"Neurologic Clinics"},{"key":"10.1002\/14651858.CD011459.pub2-BIB0035|cit35","first-page":"31","article-title":"Performance of the Dementia Severity Rating Scale: a caregiver questionnaire for rating severity in Alzheimer's Disease","volume":"10","author":"Clark","year":"1996","journal-title":"Alzheimer's Disease Association Disorders"},{"issue":"4","key":"10.1002\/14651858.CD011459.pub2-BIB0036|cit36","first-page":"722","article-title":"Nonpharmacological management of behavioural problems on persons with dementia: the TREA Model","volume":"1","author":"Cohen-Mansfield","year":"2000","journal-title":"Alzheimer's Care Quarterly"},{"issue":"6","key":"10.1002\/14651858.CD011459.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00296-011-2263-6","article-title":"A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity","volume":"32","author":"Conaghan","year":"2012","journal-title":"Rheumatology International"},{"issue":"3","key":"10.1002\/14651858.CD011459.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.maturitas.2012.04.008","article-title":"Reminiscence therapy in dementia: a review","volume":"72","author":"Coteilli","year":"2012","journal-title":"Maturitas"},{"issue":"19","key":"10.1002\/14651858.CD011459.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1021\/bi400377p","article-title":"Development and mechanism of \u03b3-secretase modulators for Alzheimer's disease","volume":"52","author":"Crump","year":"2013","journal-title":"Biochemistry"},{"issue":"4","key":"10.1002\/14651858.CD011459.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.bcp.2013.12.014","article-title":"Therapeutic implications of the prostaglandin pathway in Alzheimer's disease","volume":"88","author":"Cudaback","year":"2014","journal-title":"Biochemical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD011459.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13195-015-0117-2","article-title":"Co-morbidity and systemic inflammation as drivers of cognitive decline: new experimental models adopting a broader paradigm in dementia research","volume":"7","author":"Cunningham","year":"2015","journal-title":"Alzheimer's Research & Therapy"},{"issue":"5","key":"10.1002\/14651858.CD011459.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/gps.857","article-title":"Does aspirin affect outcomes in vascular dementia? A retrospective case-notes analysis","volume":"18","author":"Devine","year":"2003","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"7407","key":"10.1002\/14651858.CD011459.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/bmj.327.7407.128","article-title":"Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies","volume":"327","author":"Etminan","year":"2003","journal-title":"BMJ"},{"issue":"8","key":"10.1002\/14651858.CD011459.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"e0160046","DOI":"10.1371\/journal.pone.0160046.","article-title":"Bleeding risk with long-term low-dose aspirin: a systematic review of observational studies","volume":"11","author":"Garc\u00eda Rodr\u00edguez","year":"2016","journal-title":"PloS One"},{"key":"10.1002\/14651858.CD011459.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1749-6632.2010.05726.x","article-title":"Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials","volume":"1207","author":"Gorelick","year":"2010","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1002\/14651858.CD011459.pub2-BIB0046|cit46","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"issue":"9149","key":"10.1002\/14651858.CD011459.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(98)12154-2","article-title":"COX-2 inhibitors","volume":"353","author":"Hawkey","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD011459.pub2-BIB0048|cit48","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"2","key":"10.1002\/14651858.CD011459.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/ageing\/afi030","article-title":"Use of the QOL-AD for measuring quality of life in people with severe dementia: the LASER-AD study","volume":"34","author":"Hoe","year":"2005","journal-title":"Age and Ageing"},{"issue":"5","key":"10.1002\/14651858.CD011459.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1192\/bjp.bp.104.007658","article-title":"Quality of life of people with dementia living in care homes","volume":"188","author":"Hoe","year":"2006","journal-title":"British Journal of Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD011459.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/gps.1786","article-title":"Quality of life in dementia: care recipient and caregiver perceptions of quality of life in dementia: the LASER-AD study","volume":"22","author":"Hoe","year":"2007","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD011459.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/WAD.0b013e318194fc1e","article-title":"Changes in the quality of life of people with dementia living in care homes","volume":"23","author":"Hoe","year":"2009","journal-title":"Alzheimer Disease and Associated Disorders"},{"issue":"21","key":"10.1002\/14651858.CD011459.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJMoa010178","article-title":"Nonsteroidal antiinflammatory drugs and risk of Alzheimer's disease","volume":"345","author":"In't Veld","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011459.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurology"},{"issue":"2","key":"10.1002\/14651858.CD011459.pub2-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006378.pub2","article-title":"Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease","author":"Jaturapatporn","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD011459.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3233\/JAD-2006-9S308","article-title":"Cliniciopathological analysis of dementia disorders in the elderly - an update","volume":"9","author":"Jellinger","year":"2006","journal-title":"Journal of Alzheimer's Disease"},{"issue":"1","key":"10.1002\/14651858.CD011459.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/geront\/10.1_Part_1.20","article-title":"Progress in development of the index of ADL","volume":"10","author":"Katz","year":"1970","journal-title":"Gerontologist"},{"key":"10.1002\/14651858.CD011459.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in Alzheimer's disease","volume":"4","author":"Bemiller","year":"2018","journal-title":"Alzheimer's & Dementia: Translational Research & Clinical Interventions"},{"key":"10.1002\/14651858.CD011459.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1192\/apt.7.1.24","article-title":"Risk factors for dementia","volume":"7","author":"McCullagh","year":"2001","journal-title":"Advances in Psychiatric Treatment"},{"issue":"2","key":"10.1002\/14651858.CD011459.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0165-0173(95)00011-9","article-title":"The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases","volume":"21","author":"McGeer","year":"1995","journal-title":"Brain Research Reviews"},{"issue":"2","key":"10.1002\/14651858.CD011459.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1212\/WNL.47.2.425","article-title":"Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiological studies","volume":"47","author":"McGeer","year":"1996","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD011459.pub2-BIB0062|cit62","first-page":"134","article-title":"Innate inflammatory reaction of the brain in Alzheimer disease","volume":"3","author":"McGeer","year":"1997","journal-title":"McGill Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011459.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002512-200017010-00001","article-title":"Cyclo-oxygenase-2 inhibitors: rationale and therapeutic potential for Alzheimer's disease","volume":"17","author":"McGeer","year":"2000","journal-title":"Drugs Aging"},{"key":"10.1002\/14651858.CD011459.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS\/ADRDA work group under the auspices of the Department of Health and Human Services task force on Alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD011459.pub2-BIB0065|cit65","first-page":"641-52.","article-title":"Consortium to establish a registry for Alzheimer's disease (CERAD). Clinical and neuropsychological assessment of Alzheimer's disease","volume":"24","author":"Morris","year":"1988","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD011459.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/1533317512452034","article-title":"Disease modifying drugs targeting b-amyloid","volume":"27","author":"Ozudogru","year":"2012","journal-title":"American Journal of Alzheimer's Disease and Other Dementias"},{"key":"10.1002\/14651858.CD011459.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/ana.23845","article-title":"Pathogenesis of cerebral microbleeds: in vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment","volume":"73","author":"Park","year":"2013","journal-title":"Annals of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD011459.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/STROKEAHA.112.670216","article-title":"Cerebral microbleeds and cognition in patients with symptomatic small vessel disease","volume":"44","author":"Patel","year":"2013","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD011459.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40261-013-0052-6","article-title":"Relative cardiovascular and gastrointestinal safety of non-selective anti-inflammatory drugs versus cyclo-oxygenase-2 inhibitors","volume":"33","author":"Patricio","year":"2013","journal-title":"Clinical Drug Investigation"},{"key":"10.1002\/14651858.CD011459.pub2-BIB0070|cit70","unstructured":"Prince M Wimo A Guerchet M Ali GC Wu YT Prina M The world Alzheimer report 2015: the global impact of dementia: an analysis of prevalence, incidence, cost and trends www.alz.co.uk\/research\/world-report-2015"},{"issue":"4","key":"10.1002\/14651858.CD011459.pub2-BIB0071|cit71","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001296","article-title":"Aspirin for vascular dementia","author":"Rands","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011459.pub2-BIB0072|cit72","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"5","key":"10.1002\/14651858.CD011459.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0010-9452(08)70493-3","article-title":"Measures of short-term memory: a historical review","volume":"43","author":"Richardson","year":"2007","journal-title":"Cortex"},{"issue":"4","key":"10.1002\/14651858.CD011459.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0197-4580(88)80079-4","article-title":"Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease","volume":"9","author":"Rogers","year":"1988","journal-title":"Neurobiology of Aging"},{"issue":"1","key":"10.1002\/14651858.CD011459.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5853\/jos.2014.16.1.18","article-title":"Recent updates on subcortical ischaemic vascular dementia","volume":"16","author":"Roh","year":"2014","journal-title":"Journal of Stroke"},{"issue":"6","key":"10.1002\/14651858.CD011459.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/STROKEAHA.106.477315","article-title":"Clinical significance of microbleeds in subcortical vascular dementia","volume":"38","author":"Seo","year":"2007","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD011459.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa050405","article-title":"Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention","volume":"352","author":"Solomon","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD011459.pub2-BIB0078|cit78","first-page":"791","article-title":"Memory complaint after electroconvulsive therapy: assessment with a new self-rating instrument","volume":"14","author":"Squire","year":"1979","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD011459.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/WNL.48.3.626","article-title":"Risk of Alzheimer's disease and duration of NSAI use","volume":"48","author":"Stewart","year":"1997","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD011459.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000078501","article-title":"Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review","volume":"23","author":"Szekely","year":"2004","journal-title":"Neuroepidemiology"},{"key":"10.1002\/14651858.CD011459.pub2-BIB0081|cit81","first-page":"314","article-title":"The Modified Mini-Mental State (3MS) examination","volume":"48","author":"Teng","year":"1987","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD011459.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"issue":"25","key":"10.1002\/14651858.CD011459.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nature New Biology"},{"issue":"3A","key":"10.1002\/14651858.CD011459.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/S0002-9343(97)00203-9","article-title":"Mechanism of action of nonsteroidal anti-inflammatory drugs","volume":"104","author":"Vane","year":"1998","journal-title":"American Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011459.pub2-BIB0085|cit85","first-page":"e1144","article-title":"Cardiovascular risk of nonsteroidal anti-Inflammatory drugs: an under-recognized public health issue","volume":"9","author":"Varga","year":"2017","journal-title":"Cureus"},{"issue":"2","key":"10.1002\/14651858.CD011459.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.maturitas.2014.05.008","article-title":"Sex and gender differences in the causes of dementia: a narrative review","volume":"79","author":"Walter","year":"2014","journal-title":"Maturitas"},{"issue":"2","key":"10.1002\/14651858.CD011459.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3233\/JAD-141506","article-title":"Anti-inflammatory drugs and risk of Alzheimer's disease: an updated systematic review and meta-analysis","volume":"44","author":"Wang","year":"2015","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1002\/14651858.CD011459.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/01688638908400940","article-title":"The development and validity of a test battery for detecting and monitoring everyday memory problems","volume":"11","author":"Wilson","year":"1989","journal-title":"Journal of Clinical and Experimental Neuropsychology"},{"key":"10.1002\/14651858.CD011459.pub2-BIB0089|cit89","volume-title":"Dementia: a Public Health Priority","author":"World Health Organization","year":"2012"},{"key":"10.1002\/14651858.CD011459.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"f7051","DOI":"10.1136\/bmj.f7051","article-title":"Effects of socioeconomic disparities on incidence of dementia among biracial older adults: prospective study","volume":"347","author":"Yaffe","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD011459.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0022-3956(82)90033-4","article-title":"Development and validation of a geriatric depression screening scale: a preliminary report","volume":"17","author":"Yesavage","year":"1983","journal-title":"Journal of Psychiatric Research"},{"issue":"1","key":"10.1002\/14651858.CD011459.pub2-BIB0092|cit92","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011459","article-title":"Aspirin and anti-inflammatory drugs for the prevention of dementia","author":"Jordan","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T03:47:42Z","timestamp":1652759262000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011459.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Dementia and Cognitive Improvement Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,4,30]]},"references-count":92,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011459.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,30]]}}}